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The cancer stem cell (CSC) model is a prominent concept to ex-
plain heterogeneity of tumours.1 CSCs have been revealed to be a 
self- renewing subpopulation in tumours that generate various dif-
ferentiated cell populations. Characterization of CSCs has indicated 
that they are remarkably resistant to conventional radiotherapy 
and chemotherapy. Clinically, the residual populations of CSCs are 
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Objectives: The treatment of ameloblastoma, an odontogenic epithelial tumour de-
stroying jawbone, mainly depends on radical destructive resections. Other thera-
peutic options are limited by the characteristics of ameloblastoma, such as high 
recurrence rates and resistance to radiation and chemotherapy, which implies pos-
sible existence of cancer stem cells (CSCs) in ameloblastoma. Here, we identified a 
putative CSC population in immortalized and primary human ameloblastoma cells 
and examined possible therapeutic reagents to reduce the CSC population.
Methods: We	investigated	subpopulations	of	AM- 1 cell line and human ameloblas-
toma cells using immunocytochemistry and flow cytometry and the effects of Wnt 
signalling activators on the 2- and 3- dimensional cultured ameloblastoma cells using 
molecular biological analyses.
Result: Among heterogenous ameloblastoma cells, small- sized and round- shaped 
cells were found to be proliferative and expressed a marker of dental epithelial stem 
cells, SRY- box 2 (Sox2). Exogenous activation of Wnt signalling using glycogen syn-
thase kinase 3β inhibitors, lithium chloride (LiCl) and valproic acid (VPA), increased 
the cell size and decreased proliferation of cells and expression of Sox2 in 2 dimen-
sionally	cultured	AM- 1 and human primary ameloblastoma cells. Furthermore, the 
growth	of	3	dimensionally	cultured	AM- 1 cells as suspended or embedded in gel was 
suppressed by treatment with Wnt signalling activators, VPA and CHIR99021, or an-
tibodies to sclerostin, an antagonist of Wnt signalling.
Conclusion: We suggest that Wnt signalling activators are potential drug candidates 
to suppress CSCs in ameloblastoma.
2 of 14  |     KIM et al
responsible for metastasis and recurrence in cancer patients, which 
can lead to chronic and incurable cancers. Therefore, elimination of 
CSCs is an important goal for treatment of cancer.2
Ameloblastoma is the most common odontogenic tumour, ac-
counting for 1% of all tumours of the head and neck region and around 
11% of all odontogenic tumours. Classification of ameloblastomas has 
currently been established, which includes three types- conventional, 
unicystic and extraosseous/peripheral.3 Its biological behaviour is con-
sidered to be more aggressive due to its higher incidence of recurrence 
4 ; consequently, the current standard treatment is wide resection with 
appropriate margins and immediate reconstruction, which is associ-
ated with significant patient morbidity.5 Although radiotherapy has 
been attempted for decreasing the recurrence rate, its efficacy is not 
clear.5	A	systemic	genomic	analysis	showed	that	over	80%	of	amelo-
blastomas harbour oncogenic mutations in the sonic hedgehog (SHH) 
and mitogen- activated	protein	kinase	(MAPK)	pathways.6
AM- 1 is an ameloblastoma cell line that is immortalized using 
human papillomavirus type- 16.7	 The	 AM- 1 cell line exhibits char-
acteristics that are similar to in situ ameloblastoma cells related to 
marker expression and invasive properties, which shows that this 
cell line is an appropriate model system to study ameloblastoma.7- 10 
Studies	using	this	cell	line	revealed	that	Akt,	MAPK	and	SHH	signal-
ling	pathways	are	related	to	proliferation	and	apoptosis	of	AM- 1.11- 15 
Interestingly, the Wnt pathway, an osteogenic signalling pathway, is 
suppressed in this cell line.16,17 Early progeny of Sox2- positive dental 
epithelial stem cells (DESCs) are known to transiently express a Wnt 
inhibitor, secreted frizzled- related protein (Sfrp) 5.18	AM- 1 cells also 
express the Wnt antagonist Sfrp2,16 and osteogenic genes related 
to Wnt signalling are suppressed in this cell line.17 A recent study 
showed that Wnt signalling is important for enamel formation by fa-
cilitating ameloblast differentiation and movement.19
In this study, we demonstrated the presence of a putative CSC 
population	in	AM- 1, a well- established human ameloblastoma cell line. 
Immunocytochemistry	and	flow	cytometry	of	AM- 1 cells showed that 
small- sized and round- shaped cells were proliferative and expressed a 
marker of DESCs, SRY- related	HMG	box	2	(Sox2).18,20,21 Interestingly, 
Sox2 expression in the cells was negatively correlated with activation 
of Wnt signalling. We examined the effect of various exogenous Wnt 
activators	in	2	dimensionally	(2D)	or	3	dimensionally	(3D)	cultured	AM- 
1 cells and human primary ameloblastoma cells. These Wnt activators 
showed an inhibitory effect in growth of ameloblastoma cells.
2  | METHODS
2.1 | Cell culture, 3- dimensional culture and cell 
sheet generation
AM- 1 cells were cultured in keratinocyte growth medium supple-
mented with pituitary extract (Gibco, Grand Island, NY, 17005- 042) 
at 37°C and 5% CO2 in a humidified incubator. For spheroid forma-
tion, 1.0 × 105 or 2 × 105 cells were plated onto Ultra- Low Attachment 
Surface	Costar	 6	Well	 Plates	 (Corning	 Inc,	 Corning,	NY,	 4371)	with	
keratinocyte	growth	medium	or	Dulbecco's	Modified	Eagle's	Medium	
(DMEM,	 Gibco,	 11995- 065)	 supplemented	 with	 10%	 foetal	 bovine	
serum	(FBS,	Gibco,	12484- 020) and 1% penicillin/streptomycin (Gibco, 
15140- 112) solution at 37°C for 1 week. For 3- dimensional culture in 
gels, 1.0 × 103 cells were suspended in 40 μl of gels and spot into one 
well of the pre- warmed 24 well plate. The gels were solidified in 37°C 
incubator and then keratinocyte growth media supplemented with 0, 
0.6	or	1.2	mmol/L	calcium	chloride.	For	cell	sheet	generation,	AM- 1 
cells were plated onto temperature- responsive dishes (Nunc UpCell 
3.5 cm dish, ThermoFisher Scientific, Somerset, NJ, NUN- 174904) and 
cultured with keratinocyte growth medium until fully confluent. The 
confluent cells were detached in the form of a cell sheet as described 
in the manufacturer's instructions.
2.2 | Real- time PCR analysis
Total	 RNA	 of	 AM- 1 cells cultured with conventional cell culture 
methods or cultured as spheroids were extracted using Trizol™ rea-
gent	(Invitrogen	Corp.	16596026)	as	described	in	the	manufacturer's	
instructions. The extracts were reverse- transcribed	using	Maxime	
RT	PreMix	(iNtRON,	25081).	The	products	were	subjected	to	real- 
time PCR analyses with primer sets (Oct3/4, F 5'- CTG GGC TCT CCC 
ATG CAT- 3', R 5'- CCT GTC CCC CAT TCC TAG AAG- 3'; Sox2, F 5'- 
ACA GCA AAT GAC AGC TGC AAA- 3', R 5'- TCG GCA TCG CGG TTT 
TT- 3'; CD49f, F 5'- GAT CCC GGC CTG TGA TTA ATA TT- 3', R 5'- CTG 
GCG GAG GTC AAT TCT GT- 3'; Bcl11b, F 5'- GCT GGG TCC AGG 
TGA AGT GA- 3', R 5'- CGA AAG GTC CTG GCT GTG AT- 3'; Axin2, 
F 5'- CCA AGC AGA CGA CGA AGC AT- 3', R 5'- GTT TCC GGA GCC 
TTG GAG TG- 3'; GAPDH, F 5'- GAA GGT GAA GGT CGG AGT- 3', R 
5'- GAA GAT GGT GAT GGG ATT TC- 3') using the StepOnePlus Real- 
Time PCR System (ThermoFisher Scientific).
2.3 | Immunoblot analysis
AM- 1 cells were lysed in protein extraction buffer with a protease 
inhibitor	cocktail	(cOmplete	Mini,	Roche,	11836170001).	The	lysates	
were subjected to immunoblot analyses using anti- β- catenin (Santa 
Cruz Biotechnology, Santa Cruz, CA, sc- 7199) and anti- α- tubulin 
(Sigma- Aldrich,	 T6199).	 For	 visualization,	 anti- mouse or rabbit IgG 
conjugated with horseradish peroxidase (Santa Cruz Biotechnology, 
sc- 2005 and sc- 2004, respectively) was applied and visualized with 
ECL (GE Healthcare, RPN2232) using a chemiluminescence imaging 
system (Davinch- chemi, Core Bio).
2.4 | Flow cytometry
AM- 1 cells detached using trypsin- EDTA were centrifuged and re-
suspended in keratinocyte growth medium. Light scattering charac-
teristics of cells were analysed using forward scattered light (FSC) 
and side- scattered light (SSC), and based on the characteristics, cells 
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were sorted into two subpopulations using a BD FACSAria III cell 
sorter (BD Biosciences).
2.5 | Animal experiments
Female nude (nu/nu BALB/c/Bkl) mice (Nara Biotech Co.) were 
housed in a temperature- controlled room (22°C) under artificial il-
lumination (lights on from 05:00 to 17:00) and 55% relative humidity. 
Mice	had	access	to	food	and	water	ad	libitum.	For	orthotopic	grafts,	
the	upper	first	molars	of	8- week- old nude mice were extracted, and 
a hole was prepared using a portable drill with a 0.75 mm tip in the 
extraction site under deep anaesthesia. Subsequently, a properly 
sized	AM- 1	cell	sheet	was	grafted	into	the	hole	using	forceps.	AM- 1 
cell sheet- grafted mice were housed for 1 week for healing and sub-




Cells were fixed in 4% paraformaldehyde (PFA) and permeabilized 
with 0.02% Triton X- 100 in phosphate- buffered saline. Spheroids 
or decalcified tissues were fixed in 4% PFA. Staining was per-
formed on 4 μm paraffin- embedded sections. After deparaffiniza-
tion, the slides were incubated with pepsin (Digest- All™ 00- 3009, 
Invitrogen) for 15 minutes at 37°C. After blocking with 5% bovine 
serum albumin, cells were incubated with the following primary 
antibodies: anti- β- catenin (Santa Cruz Biotechnology, sc- 7199), 
anti- Sox2 (Santa Cruz Biotechnology, sc- 20088)	 and	 anti- Ki67	
(Spring	Bioscience	Corp.,	M3060).	For	visualization,	anti- mouse or 
rabbit	IgG	conjugated	with	Alexa	Fluor	488	or	555	dye	(Invitrogen)	
was	applied	and	observed	under	a	confocal	microscope	(LSM700,	
Carl Zeiss,). The cytoskeleton or nucleus was stained using 
phalloidin	 conjugated	 with	 Alexa	 Fluor	 488	 dye	 (Invitrogen)	 or	
4',6- diamidino- 2- phenylindole	 (ThemoFisher	 Scientific,	 D1306),	
respectively. The cell size and staining intensity were meas-




As previously described,7	 AM- 1 cells exhibited a heterogeneous 
morphology- from small round cells to large flattened cells. The aver-
age	cell	size	was	60.6	± 32.4 μm2, and the largest cell was 12 times 
larger than the smallest one. To detect a possible CSC population 
inside these heterogeneous cells, Sox2, a marker of DESCs,18,20,21 
was stained and visualized (Figure 1A, red). Sox2 expression sig-
nificantly differed among the cells and was especially strong in 
small round cells (Figure 1A, arrows). Quantification of the results 
revealed a negative correlation between Sox2 expression and the 
cell	size	of	AM- 1 cells (Figure 1B, Pearson's correlation coefficient 
r =	−0.616).	Additionally,	the	expression	of	Ki67,	a	marker	of	cell	pro-
liferation, showed a wide variation among the cells (Figure 1C) and 
was	also	negatively	correlated	with	cell	size	in	AM- 1 cells (Figure 1D 
r =	−0.691).
Wnt signalling, an essential signalling pathway for ameloblast 
differentiation,	 is	 known	 to	 be	 suppressed	 in	 DESCs	 and	 AM- 1 
cells.17- 19 Staining of β- catenin, an effector molecule of Wnt signal-
ling,	 revealed	 that	 it	was	 localized	differently	 in	AM- 1 cells; some 
cells displayed the presence of nuclear β- catenin, which indicates 
activation of Wnt signalling, but cytosolic β- catenin was observed 
in other cells (Figure 1E). Quantitative analysis showed that the nu-
clear localization of β- catenin was negatively correlated with Sox2 
expression (Figure 1F r =	−0.734).	Overall,	small	round	cells	showed	
significant proliferation as well as a high expression of stem cell 
markers with low Wnt signalling activity, which identified them as 
putative	CSCs	in	AM- 1 cells.
Flow cytometry analysis using FSC and SSC displayed two sub-
populations	 of	 cells	with	 different	 sizes	 in	AM- 1 cells (Figure 1G). 
After size- based cell sorting using flow cytometry, we separately 
cultured each population for one day (Figure S1 and Figure 1H- L). 
Cells expressing cytokeratin 14, a marker of epithelial stem cells, 
were found in P2 (Figure 1H, white arrows), which were relatively 
small compared with cytokeratin 14- negative cells (Figure 1I, yellow 
arrowheads). Cells in both the populations formed larger colonies 
after a 3- - culture, and the expression of Sox2 was much higher in 
the colonies of P2 compared with those of P1 (Figure 1J). Real- time 
PCR analysis showed enrichment of stemness markers (CD49 and 
Sox2) in the cells of P2 (Figure 1K,L).
3.2 | Effect of Wnt signalling activators on putative 
CSC	population	in	AM- 1 cells
To further investigate the role of Wnt signalling in putative CSCs, 
we	activated	Wnt	signalling	in	AM- 1 cells by using the Wnt signalling 
activators lithium chloride (LiCl) and valproic acid (VPA) to assess 
cellular and molecular changes (Figures 2,3). Upon treatment with 
LiCl,	the	number	of	large	flattened	cells	without	Ki67	expression	in-
creased (Figure 2A- C). Sox2 also showed a dose- dependent decrease 
after	 the	LiCl	 treatment	 (Figure	2D).	We	classified	AM- 1 cells into 
four types (Figure 2E) according to size (small or large), shape (round 
or flat), Sox2 expression (Sox2high or Sox2low) and nuclear accumula-
tion of β- catenin (nuclear β- cathigh or nuclear β- catlow). Upon treat-
ment with LiCl, type I (small, round, Sox2high and nuclear β- catlow) 
and type II (small, dented, round, Sox2high and nuclear β- catlow) cells 
increased, whereas type III (small, flat, Sox2low and nuclear β- catlow) 
and type IV cells (large, flat, Sox2low and nuclear β- cathigh) decreased 
(Figure 2F).
Treatment with VPA showed a similar result as that of LiCl. The 
number of large flat cells and expression of β- catenin in the cells 
4 of 14  |     KIM et al
increased (Figure 3A,B). The transcription of Axin2, a target gene 
of Wnt signalling, also increased in dose- dependent manner by VPA 
treatment (Figure S2). Expression of Bcl11b and Sox2 decreased 
upon VPA treatment (Figure 3C,D). An opposite effect was ob-
served in cells treated with basic fibroblast growth factor (bFGF), 
a mitogenic factor that stimulates ameloblastoma proliferation 15 
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; the number of small, round, Sox2high cells increased upon bFGF 
treatment (Figure 3E, arrows). These results show that small, round, 
Sox2high cells respond to their surrounding microenvironment, which 
is one of the basic features of CSCs.2
3.3 | In vitro spheroid- forming	capacity	of	AM- 1 cells
In vitro spheroid- forming assay is a well- established method for 
demonstrating self- renewal capacity of stem cells from various 
organs.22	 We	 plated	 various	 numbers	 of	 AM- 1 cells on low at-
tachment surface cell culture plates with several different culture 
media to optimize spheroid- forming conditions (Figure S3A). No 
spheroid formation was observed when the seeded number of cells 
was 2 × 105	 per	well	 in	 a	 6-	well	 plate	with	 keratinocyte	 growth	
medium (Figure S3A). However, the same number of cells grown 
in	DMEM	displayed	spheroid	formation	(Figure	S3A).	Interestingly,	
the dissected spheroids showed a similar structure to that of amelo-
blastoma; the hyperchromatic outer shell implied the presence of 
peripheral palisading cells at the basal layer of ameloblastoma, and 
the eosinophilic spots inside the spheroids were similar to kera-
tin pearls, typical structures found in acanthomatous ameloblas-
toma (Figure S3B). Real- time PCR showed that the expression of 
stem cell markers (OCT3/4, Sox2 and CD49f) and an anti- apoptotic 
marker (Bcl11b) increased in cells that were three dimensionally 
(3D) cultured as spheroids compared with those cultured in a con-
ventional cell culture system (Figure S3C- F).
3.4 | In vivo tumour- forming capacity of AM- 1 cells
In vivo tumour- forming	capacity	of	AM- 1 cells was assessed by or-
thotopic grafts of ameloblastoma cells (Figure S4A- D). A mass of 
AM- 1 cell sheet was implanted into a hole drilled at the extraction 
site	 of	 the	maxillary	 first	molar	 of	 8	week- old BALB/c nude mice 
(Figure S4A,B). After a week, complete closure of the extraction site 
was observed (Figure S4B, the area surrounded by the black dotted 
line). Histological analysis of the maxillary tissue revealed the for-
mation of an abnormal cell mass at the extraction site (Figure S4C, 
upper panel). Immunostaining for a human- specific antigen, human 
leukocyte antigen (HLA), showed the existence of exogenous cells 
in the mass (Figure S4C, lower panel). The exogenous cells formed 
eosinophilic structures that were suggestive of those observed in-
side	AM- 1 spheroids (Figure S4D, arrows).
3.5 | Effect of Wnt signalling activators on human 
primary ameloblastoma cells
To confirm the result based on a cancer cells- line, we investigated the 
effect of Wnt signalling activators on human primary ameloblastoma 
cells, which were freshly isolated from excised ameloblastoma tis-
sue	(Figure	4).	Similar	with	the	result	observed	in	AM- 1 cells, VPA in-
creased cell size and decreased cell proliferation in a dose- dependent 
manner (Figure 4A- C). The VPA- dose- dependent increase in β- catenin 
was also observed in the primary ameloblastoma cells (Figure S5A,B).
An antibody to sclerostin was observed to act as a bone anabolic 
agent by neutralizing antagonists of Wnt ligands.23 In our study, the 
sclerostin antibody (SOST antibody) showed similar effect with other 
chemical Wnt signalling activators; the SOST antibody increased cell 
size and decreased cell proliferation of primary ameloblastoma cells 
(Figure 4D- F).
3.6 | Effect of a Wnt signalling activator on 
suspension- cultured AM- 1 cells
To investigate the effect of Wnt signalling on the formation of 
AM- 1 spheroids, we activated Wnt signalling in the spheroids by 
treatment with VPA. The sectioned spheroids showed a dose- 
dependent decrease in size (Figure 5A,B). Immunostaining and im-
munoblotting confirmed an increase in β- catenin by VPA treatment 
of the spheroids (Figure 5C,D). With an increase in β- catenin, the 
expression	of	a	proliferation	marker,	Ki67,	and	a	stem	cell	marker,	
Sox2, was decreased (Figure 5C- H). However, cleaved Caspase 
3, a marker of apoptosis, was not changed by VPA treatment 
(Figure	S6).
The	 SOST	 antibody	 also	 reduced	 the	 size	 of	 AM- 1 spheroids 
(Figure	6A,B).	The	β- catenin level was increased, and the number of 
Ki67- positive cells decreased in the spheroids after treatment with 
the	antibody	(Figure	6C-	F).	Notably,	the	expression	of	ameloblastin,	
a marker of ameloblast differentiation, was increased by the anti-
body	(Figure	6G,H).	However,	no	significant	effect	of	the	antibody	
was	observed	on	the	apoptosis	of	AM- 1 spheroids (Figure S7).
F I G U R E  1  AM-	1	harbours	a	cancer	stem	cell-	like	population.	A- F,	AM- 1 cells were subjected to immunocytochemistry (ICC) using 
antibodies	to	Sox2	(A,	E),	Ki67	(B),	or	β- catenin (E). Small round cells strongly expressing Sox2 are indicated by white arrows (A). The cell size 
(B, D), Sox2 intensity (B, F), or ratio of nuclear to cytosolic β- catenin (F) of each cell were measured and are displayed as a dot plot. A trend 
line (dotted line) shows the relationship between the measured factors (B, D and F). Cytoskeletons (A and C) and nuclei (A, C and E) were 
visualized	using	Alexa	488- conjugated phalloidin (green) and DAPI (blue), respectively. Scale bar = 20 μm. G- J, Scattered light characteristics 
of	AM- 1	cells	based	on	forward	scattered	light	(FSC)	and	side	scattered	light	(SSC).	AM- 1 cells were sorted into two groups (P1 and P2) 
based on FSC and SSC (G) and cultured for 1 (H, I) or 3 d (J). Three dimensionally reconstructed image (H, I) and conventional confocal image 
(J). The cells were subjected to ICC using an antibody to Cytokeratin 14 and Sox2 (H- J). Cytoskeletons and nuclei (H- J) were visualized 
using fluorophore- conjugated phalloidin and DAPI (blue), respectively. Scale bar = 100 μm. K- L,	Total	RNA	of	AM- 1 cells in P1 and P2 were 
extracted and subjected to real- time PCR analyses using primer sets of CD49f (K) and Sox2 (L). RQ, relative quantity. n = 3
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F I G U R E  2   Treatment with lithium chloride increased the cell size and decreased proliferation and expression of stem cell markers of 
AM- 1 cells. A- F,	AM- 1 cells were cultured for 24 h with the indicated dose of lithium chloride (LiCl). The cells were subjected to ICC using 
antibodies	to	Ki67	(A),	β- catenin,	or	Sox2	(D).	Cytoskeletons	(A)	and	nuclei	(A,	D)	were	visualized	using	Alexa	488- conjugated phalloidin 
(green)	and	DAPI	(blue),	respectively.	Distribution	of	cell	size	(B)	and	ratio	of	cell	populations	classified	by	Ki67	expression	pattern	(C;	none,	
partially,	or	fully	covered	nucleus	with	Ki67)	or	by	size,	shape,	Sox2	expression	and	nuclear	accumulation	of	β- catenin (E and F, class I- IV) 
were analysed and are displayed as a graph (B, C and F). The average cell size in each group is indicated by a red bar (B). Scale bar = 20 μm
F I G U R E  3   Treatment with valproic acid increased the cell size and decreased proliferation and expression of stem cell markers of 
AM- 1 cells. A- E,	AM- 1 cells were cultured for 24 h with 1 mmol/L valproic acid or 100 mg/ml basic fibroblast growth factor (bFGF). The 
cells were subjected to ICC using antibodies to β- catenin (A) and Sox2 (E), and immunoblotting using antibodies to β- catenin or α- tubulin 
(B).	Cytoskeletons	and	nuclei	were	visualized	using	Alexa	488- conjugated phalloidin (green) and DAPI (blue), respectively (A, E). Scale 
bar = 20 μm. Total RNA of the cells was extracted and subjected to real- time PCR analyses using primer sets of Bcl11b (C) and Sox2 (D). 
n = 3. VPA, valproic acid. RQ, relative quantity
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3.7 | Effect of a Wnt signalling activator on 3D- 
cultured AM- 1 cells in gels
Recent advances in 3D cell culture have enabled the development 
of more physiological in vitro models using cancer cells.24 First, 
we	tried	3D	culture	of	AM- 1	cells	in	Matrigel,	a	well- defined solu-
ble basement membrane used widely.25	Initially,	we	cultured	AM- 1 
cells	 in	3D	Matrigel	using	a	keratinocyte	medium.	The	cells	were	
observed	to	proliferate	in	Matrigel;	however,	they	formed	loosely	
connected cell masses (Figure 7A). When Ca2+ was supplied to 
the	 medium,	 AM- 1 cells adhered to each other to form tightly 
compacted cell spheroids (Figure 7B). The spheroids showed a 
complex structure – a basal cell- like hematoxylinophilic outer 
region and keratinizing eosinophilic inner region were observed 
(Figure 7B). In both cases, exogenous activation of Wnt signalling 
using CHIR99021, a GSK3β inhibitor, suppressed proliferation and 
F I G U R E  4   Treatment with VPA or α- SOST	increased	the	cell	size	and	decreased	proliferation	and	expression	of	stem	cell	markers	of	AM- 
1 cells. A- F,	AM- 1 cells were cultured for 24 h with the indicated dose of VPA or α- SOST. The cells were subjected to ICC using antibodies to 
cytokeratin	14	(K14,	green)	and	Ki67	(red).	Nuclei	were	visualized	using	DAPI	(blue),	respectively.	Cell	size	(B	and	E)	and	ratio	of	Ki67- positive 
cells per total cells (C and F) were analysed and are displayed as a graph. Scale bar = 100 μm, *p- value < 0.05, **p- value < 0.01.
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mass formation of the cells (Figure 7C). Next, to provide an en-
vironment more similar to an in vivo microenvironment, we cul-
tured the cells in collagen gel. Interestingly, a network- like growth 
pattern	of	AM- 1 cells was observed in the collagen gel (Figure 7D). 
In addition, the cells formed more prominent and thicker networks 
at higher concentrations of Ca2+ and collagen (Figure 7E). Wnt 
F I G U R E  5  Suspended	culture	of	AM- 1 cells and effects of VPA on the growth. A- H, Two- hundred- thousand	AM- 1 cells were plated 
on a well of a low- attachment	surface	6- well	cell	culture	plate	and	cultured	for	7	d	in	DMEM	with	or	without	VPA.	Sections	of	spheroids	
were subjected to H&E staining (A), immunohistochemistry using antibodies to β- catenin	(C,	red),	Ki67	(E,	red)	and	Sox2	(G,	red);	and	
immunoblotting using antibodies to β- catenin or GAPDH (D). Nuclei were visualized using (C, E and G, blue). Scale bar = 200 μm. The size 
of	sectioned	spheroids	(B)	and	ratio	of	Ki67- positive (F) or Sox2- positive (H) nuclei were quantified. n = 50. **p- value < 0.01. VPA, valproic 
acid, TP3, TO- PRO- 3
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F I G U R E  6  Suspended	culture	of	AM- 1 cells and effects of sclerostin antibody on their growth. A- H, Two- hundred- thousand	AM- 1 cells 
were plated on a well of low- attachment	surface	6	well	cell	culture	plate	and	cultured	for	7	d	in	DMEM	with	or	without	sclerostin	antibody	
(α- SOST). Sections of spheroids were subjected to H&E staining (A); immunohistochemistry using antibodies to β- catenin	(C,	green),	Ki67	(E,	
red), and ameloblastin (G, green); and immunoblotting using antibodies to β- catenin or anti- GAPDH (D). Nuclei were visualized using TP3. 
Scale bar = 200 μm.	The	size	of	sectioned	spheroids	(B)	and	ratio	of	Ki67- positive (F) or Sox2- positive (H) nuclei were quantified. n = 50. **p- 
value < 0.01. α- SOST, anti- SOST antibody, TP3, TO- PRO- 3
F I G U R E  7   Three- dimensional	culture	of	AM- 1 cells and effects of Wnt activators on their growth. A- F,	AM- 1	cells	embedded	in	Matrigel	
(A- D)	or	collagen	gel	(1	mg/ml	for	D,	2	mg/ml	for	F,	and	E	as	indicated)	were	grown	in	keratinocyte	media	with	(KRCMC,	0.6	mmol/L	for	a- d, 
1.2 mmol/L for F, and E as indicated) or without Ca2+	supplement	(KRCM)	for	14	days.	VPA	was	added	to	the	media	at	the	indicated	doses	
(F). Scale bar = 100 μm. VPA, valproic acid
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signalling activators, VPA and CHIR99021, suppressed growth of 
the cells in the collagen gel in a dose- dependent manner (Figure 7F 
and	Figure	S8).
4  | DISCUSSION
Radical surgery is the current mainstay of ameloblastoma treat-
ment and includes an en bloc resection of 1- 2 cm of the bone adja-
cent to the ameloblastoma, which usually requires immediate bone 
reconstruction for speech and swallowing. This reconstruction is 
not necessary for conservative surgery, such as simple enucleation 
or curettage of the bone margin. However, the rate of recurrence 
after	 these	 operations	 can	 be	 as	 high	 as	 60%-	90%.5 With such 
high recurrence rates, the characteristics of ameloblastoma, such 
as slow- and long- term proliferation, resistance to radiation and 
chemotherapy, and complex histological structures within the tu-
mours, strongly imply the possible existence of CSCs in ameloblas-
toma. However, very few pathological studies have reported stem 
cell marker staining in tumour tissue,22,26 and the characteristics 
and roles of CSCs in tumorigenesis remain to be elucidated. In this 
study,	we	characterized	a	putative	CSC	population	in	AM- 1 cells, 
a well- established human ameloblastoma cell line. We observed 
that	the	small	round	cell	population	of	AM- 1 cells was proliferative 
and	expressed	a	stem	cell	marker.	We	also	found	that	AM- 1 cells 
possessed spheroid- forming capacity, which is an indicator for 
stemness	of	 cells.	 In	addition,	 the	orthotopic	graft	of	AM- 1 cells 
formed a mass that exhibited keratinization. These findings may 
serve to pave the way to study CSC populations of ameloblastoma 
in vitro.
Wnt signalling is an osteogenic signalling pathway that pro-
motes bone generation by activating osteogenesis and inhibiting 
osteoclastogenesis.27 In tooth development, Wnt signalling is 
known to be activated in the late stage of development and facil-
itates ameloblast differentiation and movement.19 Expression of 
Sfrp, an antagonist of Wnt signalling, is observed in Sox2- positive 
DESCs.18	Interestingly,	AM- 1 cell line also expresses the Wnt an-
tagonist Sfrp2,16 and osteogenic genes related to Wnt signalling 
are suppressed in this cell line.17 Here, we revealed that the Sox2- 
positive	population	of	the	AM- 1 cell line showed low Wnt signal-
ling activity. Exogenous activation of Wnt signalling by treatment 
with chemical Wnt activators (LiCl, VPA and CHIR9902) reduced 
the number of Sox2- positive cells, spheroid- forming capacity and 
invasiveness	of	AM- 1	cells	into	collagen	gel	(Figure	8).	Recently,	a	
sclerostin antibody was approved as a therapeutic agent against 
osteoporosis.28 The antibody activates Wnt signalling by neutral-
izing sclerostin, a Wnt antagonist secreted by mature osteocytes, 
to prevent excessive osteogenesis.29 A recent study revealed that 
treatment with the antibody stimulates mandibular bone forma-
tion.23 In our study, treatment with sclerostin antibody activated 
Wnt	signalling	and	 suppressed	 the	 formation	of	AM- 1 spheroids 
(Figure	 8).	 The	 effect	 of	 Wnt	 signalling	 activators	 was	 clearly	
F I G U R E  8   Schematic diagram for the 
effect of Wnt signalling activators on 
ameloblastoma. Exogenous activation 
of Wnt signalling using antibody (α- 
SOST antibody) or chemicals (LiCl, 
VPA, or CHIR9902) increases β- catenin 
(β- cat) in ameloblastoma, leading to an 
increase in β- cathigh and Sox2-  cells and 
decrease in β- catlow and Sox2+ cells, the 
putative cancer stem cells. This change of 
subpopulation in ameloblastoma results 
in the suppression of spheroid- forming 
activity and invasiveness
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confirmed by human primary ameloblastoma cells. Taken together, 
we suggest that treatment with Wnt activators is a potential ther-
apeutic option after resection of ameloblastoma, which promotes 
bone	healing	along	with	suppression	of	tumour	recurrence.	AM- 1 
cells showed anchorage- independent growth, which is a property 
of transformed cells.30	Proliferation	of	AM- 1 cells was observed 
in a suspension culture containing keratinocyte growth medium 
that had a low calcium concentration,31 as well as that contain-
ing	 DMEM.	 However,	 spheroid	 formation	 was	 only	 observed	 in	
suspension	culture	containing	DMEM.	The	suspended	AM- 1 cells 
in	 DMEM	 formed	 compact	 and	 round	 spheroids	 that	 were	 ap-
proximately 200 μm in diameter. By contrast, small and loosely 
connected cell masses were observed in the keratinocyte growth 
medium. A similar phenomenon was observed in 3D cultures using 
Matrigel	and	collagen	gel.	Calcium	is	known	to	be	an	important	co- 
factor of cell adhesion molecules that affects cell differentiation 
and migration.32 Further studies are required to reveal the role of 
calcium in spheroid- forming	activity	of	AM- 1	cells.	Notably,	AM- 1 
cells showed network- like growth in collagen gel, which is similar 
to the growth pattern of plexiform ameloblastoma. In addition, 
culture conditions should be further optimized to represent more 
characteristics, such as reverse polarization of cells from the base-
ment membrane of ameloblastoma.
5  | CONCLUSION
In conclusion, we identified putative CSC population in human im-
mortalized and primary ameloblastoma cells. Furthermore, we 
showed that exogenous activation of Wnt signalling decreased the 
CSC population and suppressed their 2- and 3- dimensional growth 
of ameloblastoma cells. This finding suggests that the Wnt signalling 
activators could be developed as drugs suppressing CSCs in amelo-
blastoma, which could provide an alternative option to treat cancer 
without radical destructive surgery.
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